Inhaltsseite: Home

Yield Enhancement

Pharma and Biotech: Up to 22.5%

Friday, 10 December 2021 Reading time : 2 minutes

Impfstoffproduzenten: Hohe Volatilität, hoher Coupon
BRC auf Biontech und Moderna (USD/CHF)

  • 22.5% / 21.5% Coupon p.a.
  • Defensive Barriere bei 50%
  • 12 Monate Laufzeit
  • Zeichnungsfrist 13. Dezember 2021
  • Termsheet USD
  • Termsheet CHF


Schweizer Werte, niedrige Korrelation
BRC auf Lonza, Alcon und Roche (CHF)

  • 9% Coupon p.a.
  • Barriere bei 69%
  • 12 Monate Laufzeit
  • Zeichnungsfrist 13. Dezember 2021
  • Termsheet CHF


BRC auf Roche, Straumann, Vifor und Alcon

  • 10% Coupon p.a.
  • Barriere bei 67%
  • 12 Monate Laufzeit
  • Zeichnungsfrist 14. Dezember 2021
  • Termsheet CHF


Etablierte europäische Pharmakonzerne

Callable BRC auf Bayer, Sanofi und Novartis (EUR/CHF)

alle Angaben indikativ
 

Disclaimer
This communication is for marketing purposes. It is neither an offer nor an invitation to submit an offer, to purchase or to subscribe to securities and does not constitute investment advice. You should consult your advisors before making an investment decision.
Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, financial condition, development or performance of the issuer to be materially different from any future results, financial condition, development or performance expressed or implied by such statements.
The present document has not been drawn up by the research department as defined in the rules of the “Directives on the Independence of Financial Research” published by the Swiss Bankers Association, hence these rules do not apply to this document.
If securities are mentioned in the communication, the base prospectus, the final terms and any key information document may be obtained free of charge from Zürcher Kantonalbank, Bahnhofstrasse 9, 8001 Zurich, VRIS, and from www.zkb.ch/finanzinformationen. 

 


Ajax loading